Priority Date: 14.12.12 (CN 201210543652)

MONOCLONAL ANTIBODY FOR ANTAGONIZING AND INHIBITING BINDING OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND ITS RECEPTOR, AND CODING SEQUENCE AND USE THEREOF

  • Application ID: EP13863651
  • Status: The patent has been granted

Attorney

no operation time available
Headquarter in Bristol and 7 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 122 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 14.12.2012 - Priority Date (CN 201210543652)
  • 19.06.2014 - Publication A1 (WO2014090053)
  • 21.10.2015 - Publication A1 (EP2933266)
  • 09.01.2019 - Publication B1 (EP2933266)